N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells

Non-small cell lung cancer (NSCLC) is a major subtype of lung cancer and is the most common and fatal cancer worldwide. Specific tyrosine kinase inhibitors for epidermal growth factor receptor (EGFR), such as gefitinib, have been effective in some NSCLC patients and are being used in the clinical se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yamauchi, Mai, Yoshino, Ikuyo, Yamaguchi, Rui, Shimamura, Teppei, Nagasaki, Masao, Imoto, Seiya, Niida, Atsushi, Koizumi, Fumiaki, Kohno, Takashi, Yokota, Jun, Miyano, Satoru, Gotoh, Noriko
Format: Artigo
Sprache:Inglês
Veröffentlicht: e-Century Publishing Corporation 2011
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3196281/
https://ncbi.nlm.nih.gov/pubmed/22016830
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge